23 Mar 2021 09:48
AIM share code: DVRG
23 March 2021
DeepVerge PLC
("DeepVerge" or "Company")
Exercise of Warrants
DeepVerge announces that it has received notification from a warrant holder to exercise warrants over 35,714 shares in the share capital of DeepVerge ("the Warrant Shares") at an exercise price of 20 pence. The consideration for the exercise of the Warrant Shares amounts, in aggregate, to a cash value of £7,142.80
The Warrant Shares were allotted on 23 March 2021. Application has been made for the Warrant Shares to be admitted to trading on AIM ("Admission"), and Admission is expected to be on or about 29 March 2021. These shares will rank pari passu with the ordinary shares of the Company in issue.
Total voting rights
The Company's total issued capital, after the issue of the Warrant Shares, will be 173,098,989 ordinary shares. As the Company does not hold any shares in Treasury, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company following Admission.
Contacts
DeepVerge plc | Gerard Brandon, CEO | +44 (0) 7340 055 648 |
SPARK Advisory Partners Limited (Nominated Adviser) | Neil Baldwin/Andrew Emmott | +44 (0) 113 370 8974 |
Turner Pope Investments (TPI) Limited (Broker) | Andy Thacker/Zoe Alexander | +44 (0) 20 3657 0050 |
About DeepVerge plc (www.deepverge.com)
DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins. Utilising artificial intelligent data analytics to scientifically prove the impact of skincare product claims on skin microbiome for most of the top 20 global cosmetic company clients and remotely detect and identify in real-time, dangerous pathogens in wastewater treatment plants, drinking water, rivers, lakes and reservoirs.